Home › Laryngeal Cancer › Kansas › Kansas City
Laryngeal Cancer clinical trials in Kansas City, KS
5 studies for Laryngeal Cancer are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RecruitingPhase 2
- University of Kansas Cancer Center, Kansas City
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- University of Kansas Cancer Center, Kansas City
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RecruitingPhase 1
- University of Kansas Cancer Center, Kansas City
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- University of Kansas Cancer Center, Kansas City
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RecruitingPhase 3
- University of Kansas Cancer Center, Kansas City
Laryngeal Cancer trials in other cities
- Atlanta, GA8 studies
- Chicago, IL8 studies
- Milwaukee, WI8 studies
- Kansas City, MO7 studies
- Portland, OR7 studies
- St. Louis, MO7 studies
- Edison, NJ6 studies
- Richmond, VA6 studies
- Baltimore, MD6 studies
- Cincinnati, OH6 studies
- Durham, NC6 studies
- Pittsburgh, PA6 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Heart Failure13 studies
- Obesity13 studies
- Interstitial Lung Diseases13 studies
- Cystic Fibrosis13 studies
- Breast Cancer12 studies
- Bladder Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- COPD9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.